New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 24, 2014
09:37 EDTMYGNMyriad Genetics price target increased to $48 from $39 at Stephens
Stephens said a recent meeting with Myriad Genetics' management makes the firm more bullish on the near-term and long-term prospects for the company. The firm raised its price target on the stock to $48 and reiterates its Overweight rating on the shares.
News For MYGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 21, 2015
06:40 EDTMYGNStart-up to offer saliva test for breast cancer susceptibility, NY Times says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use